In Vivo · 2018 · 29 citations · 22 references
Life SciencesOncologyPharmacologyApoptosisCancer PharmacologyMolecular OncologyApoptosis In CancerApoptosis ModulationApoptosis PharmacologyApoptosis RegulationApoptotic SignalingIntrinsic Apoptotic PathwayAnti-apoptotic ProteinsAnticancer ActivityExtrinsic Apoptosis PathwayNf-kappa B-mediated Anti-apoptotic SignalingNf-κb SignalingNuclear Factor Kappa B ActivationNuclear Factor Kappa B InhibitionWestern Blotting
The goal of the present study was to investigate anticancer effect of amentoflavone on glioblastoma cells in vitro. Our results demonstrated that amentoflavone not only significantly reduced cell viability, nuclear factor-ĸappa B (NF-ĸB) activation, and protein expression of cellular Fas-associated protein with death domain-like interleukin 1 beta-converting enzyme inhibitory protein (C-FLIP) and myeloid cell leukemia 1 (MCL1), but significantly triggered cell accumulation at the sub-G<sub>1</sub> phase, loss of mitochondrial membrane potential, and expression of active caspase-3 and -8. In order to verify the effect of NF-ĸB inhibitor on expression of anti-apoptotic proteins, we performed western blotting. We found that the of NF-ĸB inhibitor or amentoflavone markedly diminished protein levels of MCL1 and C-FLIP. Taken all together, our findings show that amentoflavone induces intrinsic and extrinsic apoptosis and inhibits NF-ĸB-modulated anti-apoptotic signaling in U-87 MG cells in vitro.
22
c-FLIP, a master anti-apoptotic regulator.
Ahmad R. Safa · PubMed · 2012 · 241 citations
Analysis of the activation status of Akt, NFκB, and Stat3 in human diffuse gliomas
Huamin Wang, Hua Wang, Wei Zhang et al. · Laboratory Investigation · 2004 · 209 citations · Full text
Medicine, Cancer Biology, Oncology +14